XM57B1ICD-11 MMS 2026-01
Mycophenolic acid
Index terms
- Mycophenolic acid
Sibling codes
XM0700– OzanimodXM09N4– ImlifidaseXM0V48– UpadacitinibXM1835– TeriflunomideXM1PC0– AnifrolumabXM1PY3– AlefaceptXM1SM6– BaricitinibXM2B74– OcrelizumabXM2Q51– Antithymocyte immunoglobulin (rabbit)XM31G3– RavulizumabXM3F23– EmapalumabXM3KK5– EculizumabXM3RJ6– PeficitinibXM3TG8– Antilymphocyte immunoglobulin (horse)XM45M8– AbataceptXM4FP8– BelataceptXM4RN7– AbetimusXM5M04– LeflunomideXM5MC2– VedolizumabXM69Y4– PonesimodXM6N55– SiponimodXM6PD2– SutimlimabXM6QJ6– BelumosudilXM75G0– GusperimusXM76R4– SirolimusXM7BS8– BegelomabXM7U27– TofacitinibXM8913– PegcetacoplanXM8AR9– TeprotumumabXM8CX4– EfalizumabXM93Q8– DeucravacitinibXM9K56– FingolimodXM9M75– BelimumabXM9RY3– Muromonab-CD3XM9UD1– ApremilastXM9YN4– Natalizumab
Foundation entity
Part of: XM5140: Selective immunosuppressants › XM6WT8: Agents primarily affecting blood constituents or immune system › XM6S30: Medicaments › X: Extension Codes